Nanoparticle Encapsulation for Antiretroviral Pre-Exposure Prophylaxis

HIV continues to be one of the greatest challenges facing the global health community. More than 36 million people currently live with HIV and, in 2015 2.1 million new infections were reported globally. Pre-Exposure Prophylaxis (PrEP) prevents HIV infection by inhibiting viral entry, replication, or...

Descripción completa

Detalles Bibliográficos
Autores principales: Khandalavala, Karl, Mandal, Subhra, Pham, Rachel, Destache, Christopher J., Shibata, Annemarie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987555/
https://www.ncbi.nlm.nih.gov/pubmed/29881781
http://dx.doi.org/10.15436/2377-1372.17.1583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987555/
https://www.ncbi.nlm.nih.gov/pubmed/29881781
http://dx.doi.org/10.15436/2377-1372.17.1583

Ejemplares similares